Core mutations, <it>IL28B </it>polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection
<p>Abstract</p> <p>Background</p> <p>Patients infected with hepatitis C virus (HCV) genotype 1 respond poorly to standard treatment with 50% or less achieving sustained virologic response. Predicting outcome is essential and could help avoid unnecessary treatment and reduce health cost. Recently, an...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2011-05-01
|
| Collection: | BMC Infectious Diseases |
| Accès en ligne: | http://www.biomedcentral.com/1471-2334/11/124 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|